Clinical evidence indicates that the fatal outcome observed with severe acute respiratory
syndrome-coronavirus-2 infection often results from alveolar injury that impedes airway …

Abstract Interleukin-6 (IL-6), known as an inflammatory cytokine, can be involved in many
innate and adaptive immune responses. The role of IL-6 in the pathogenesis of the novel …

Objective To explore the clinical value of immune-inflammatory markers to assess the
severity of coronavirus disease 2019 (COVID-19). Methods 127 consecutive hospitalized …

Progression to severe disease is a difficult problem in treating coronavirus disease 2019
(COVID‐19). The purpose of this study is to explore changes in markers of severe disease in …

Background The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan City, China
has spreads rapidly since December, 2019. Most patients show mild symptoms, but some of …

The recent SARS-CoV-2 pandemic manifests itself as a mild respiratory tract infection in
most individuals, leading to COVID-19 disease. However, in some infected individuals, this …

Abstract Background Coronavirus disease-2019 (COVID-19) is a global pandemic and high
mortality rate among severe or critical COVID-19 is linked with SARS-CoV-2 infection …

В декабре 2019 г. в г. Ухань (провинция Хубэй, расположенная в центральном регионе
Китая) зарегистрирована вспышка новой инфекции, получившей рабочее название …

Abstract Background Since December 2019, a cluster of coronavirus disease 2019 (COVID-
19) occurred in Wuhan, Hubei Province, China and spread rapidly from China to other …

Background An association between IL-6 levels and cytokine storm syndrome in COVID-19
patients has been suggested. Cases with higher IL-6 levels have more rapid progression …